TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
PCAT1 |
|
prostate cancer associated transcript 1
|
|
|
0.575 |
0.615 |
DRAIC |
|
downregulated RNA in cancer, inhibitor of cell invasion and migration
|
|
|
0.736 |
0.423 |
CASC19 |
|
cancer susceptibility 19
|
|
|
0.769 |
0.423 |
ACOXL-AS1 |
|
ACOXL antisense RNA 1
|
|
|
0.861 |
0.154 |
FARP2 |
O94887
|
FERM, ARH/RhoGEF and pleckstrin domain protein 2
|
|
4.6E-36 |
0.678 |
0.615 |
TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
QPCT |
Q16769
|
glutaminyl-peptide cyclotransferase
|
Enzyme
|
1.2E-15 |
0.568 |
0.731 |
ACOXL |
Q9NUZ1
|
acyl-CoA oxidase like
|
Enzyme
|
5.2E-15 |
0.674 |
0.577 |
OPRM1 |
P35372
|
opioid receptor mu 1
|
G-protein coupled receptor
|
7.9E-11 |
0.457 |
0.808 |
SP140 |
Q13342
|
SP140 nuclear body protein
|
|
5.0E-08 |
0.691 |
0.577 |
CASP8 |
Q14790
|
caspase 8
|
Enzyme
|
3.7E-06 |
0.404 |
0.923 |
BAK1 |
Q16611
|
BCL2 antagonist/killer 1
|
Signaling
|
7.4E-06 |
0.555 |
0.769 |
FKRP |
Q9H9S5
|
fukutin related protein
|
|
9.8E-06 |
0.513 |
0.731 |
HLA-DQA2 |
P01906
|
major histocompatibility complex, class II, DQ alpha 2
|
Immune response
|
1.0E-05 |
0.617 |
0.769 |
CLPTM1L |
Q96KA5
|
CLPTM1 like
|
Enzyme
|
4.4E-05 |
0.551 |
0.654 |
IPCEF1 |
Q8WWN9
|
interaction protein for cytohesin exchange factors 1
|
|
1.6E-03 |
0.821 |
0.269 |
C11orf21 |
Q9P2W6
|
chromosome 11 open reading frame 21
|
|
1.6E-02 |
0.821 |
0.192 |
HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
MYNN |
Q9NPC7
|
myoneurin
|
|
0.57 |
0.722 |
0.423 |
GGNBP1 |
Q5YKI7
|
gametogenetin binding protein 1 (pseudogene)
|
|
0.69 |
0.769 |
0.462 |
FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
POT1 |
Q9NUX5
|
protection of telomeres 1
|
Nucleic acid binding
|
0.85 |
0.560 |
0.731 |